SAFETY ASPECTS OF USING DROTAVERINE IN OBSTETRIC PATIENTS
Summary Safety of pharmacotherapy during pregnancy is of paramount importance for the woman and the fetus. There is an increasing number of pediatric diseases with unclear or presumably genetic etiology (autism, mental illness, oncology, obesity, diabetes, etc.). In this respect, more attention is b...
Saved in:
| Main Author: | E. M. Dzhobava |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2018-05-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/470 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY
by: A. L. Unanyan, et al.
Published: (2015-03-01) -
Features of Diagnosis and Intensive Care of Drotaverine Poisoning at the Prehospital Stage (on the Example of a Case Study)
by: V. Yu. Pikovsky, et al.
Published: (2022-09-01) -
Carcinoma of the uterine cervix in pregnancy: A study of the incidence and treatment in the Western region of Sweden 1973 to 1992
by: Anders Norström, et al.
Published: (1997-06-01) -
The cervical microbiome of ewe breeds with known divergent fertility following artificial insemination with frozen-thawed semen
by: Simen Foyn Nørstebø, et al.
Published: (2025-04-01) -
Abdominal pregnancy: two cases of critical obstetric conditions with different perinatal outcomes. Case report
by: Tatiana E. Belokrinitskaya, et al.
Published: (2025-01-01)